Status:
RECRUITING
Natural History Study of Usher Syndrome ( Light4Deaf )
Lead Sponsor:
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Collaborating Sponsors:
Assistance Publique - Hôpitaux de Paris
Conditions:
Usher Syndromes
Eligibility:
All Genders
Brief Summary
Clinical centres in the LIGHT4DEAF consortium have developed and will continue to improve a reliable, early molecular diagnosis and protocols for full clinical characterisation of Usher syndrome, whic...
Detailed Description
Our cohort study aims at precisely documenting ophthalmic, auditory, vestibular, cogninitive alterations over time with phenotype/genotype correlation Ophthalmological assessment; Best corrected visua...
Eligibility Criteria
Inclusion
- Patient with a molecular diagnosis of Usher syndrome type I, II or III or a clinical diagnosis of Usher syndrome type I, II or III which will then be confirmed by a molecular diagnosis
- Health insurance beneficiary
- Informed consent signed by the patient or their legal representatives
Exclusion
- • Patient or his/her legal representatives unable to understand the study and for whom informed consent cannot be obtained
Key Trial Info
Start Date :
June 8 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 8 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04665726
Start Date
June 8 2017
End Date
June 8 2027
Last Update
December 14 2020
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Paris, France, 75012
2
CHU Pitié Salpêtrière
Paris, France, 75013
3
CHU Necker
Paris, France, 75015
4
CHU Robert Debré
Paris, France, 75019